ELIZABETH HOCKER: Open Payments
NPI 1831784792 · FRANKFORT, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$498 in 19 payments from 11 companies in 2025. Trend: 2023 $1,121 · 2024 $555 · 2025 $498
Food & beverage: $498
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $114 |
| GlaxoSmithKline, LLC. | 4 | $89 |
| Merck Sharp & Dohme LLC | 3 | $57 |
| Janssen Biotech, Inc. | 2 | $56 |
| Novartis Pharmaceuticals Corporation | 2 | $54 |
| GENZYME CORPORATION | 1 | $27 |
| Cumberland Pharmaceuticals, Inc. | 1 | $24 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| Verastem, Inc. | 1 | $21 |
| Agios Pharmaceuticals, Inc. | 1 | $18 |
Products named: DATROWAY, JEMPERLI, KEYTRUDA, PLUVICTO, CARVYKTI, AYVAKIT, SANCUSO, TECVAYLI.
Industry payments across KY — which companies pay providers there.
